Company · CIK 0001740279
IN8BIO, INC.
INABSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$0.90−$0.08 (−8.03%)
INAB · Last trade
- Prev close
- $0.98
- Range (30d)
- $0.90 – $1.42
On the record
Recent filings
- SCHEDULE 13G/AINABIN8BIO, INC.0000935836-26-000398 · 12.3 KBSEC(opens sec.gov)
- 10-QINABQuarterly update0001193125-26-338012 · 10.2 MBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-337944 · 418.5 KBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-249684 · 432.1 KBSEC(opens sec.gov)
- 10-QINABQuarterly update0001193125-26-212135 · 9.1 MBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-212128 · 884.7 KBSEC(opens sec.gov)
- 10-KINABAnnual report0001193125-26-104181 · 37.1 MBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-104144 · 393.9 KBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-082539 · 139.9 KBSEC(opens sec.gov)
- 8-KINABCurrent report0001193125-26-041975 · 140.9 KBSEC(opens sec.gov)
Insiders
- Beelen MelissaVP, Clinical Operation
- BIOS Advisors GP, LLC10% Owner
- BIOS Capital Management, LP10% Owner
- Bios Clinical Opportunity Fund, LP10% Owner
- Bios Equity Partners II, LP10% Owner
- Bios Equity Partners, LP10% Owner
- BIOS Fund III, LP10% Owner
- BIOS Fund III QP, LP10% Owner
- BIOS Fund II, LP10% Owner
- BIOS Fund II NT, LP10% Owner
Tickers
Addresses
business
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
mailing
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
Former names
- Incysus Therapeutics, Inc.2018-09-20
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies